Adams Street Just Raised $5 Billion for Secondaries. Here's What That Tells You About Private Equity's Exit Problem

Adams Street Partners just closed its eighth flagship secondaries vehicle, Global Secondary Fund 8, at $2.7 billion, and with $2.3 billion in related separately managed accounts stacked on top, the Chicago-based firm now has more than $5 billion to deploy into the private equity secondary market. That is roughly 50% larger than the $3.2 billion the firm raised for its prior secondaries program in 2023, and it beat its own $2 billion target for the flagship fund by a wide margin. You can read the firm's own announcement here: Adams Street Raises Over $5 Billion for Secondaries Investment Program.

I've covered a lot of fund closes this year. Most of them get a paragraph. This one gets a full article, because the size of the jump, and the timing, tell you something concrete about where institutional money thinks the private equity market is headed over the next three to five years. It is headed toward more forced sellers, more patient buyers, and a secondaries market that Evercore now pegs at $226 billion in 2025 volume, up 41% year over year. That is the first time the market has crossed $200 billion. Adams Street's raise did not happen in a vacuum. It happened because the plumbing of private equity is backing up, and secondaries funds are the pressure relief valve.

What Adams Street actually raised, and how it plans to spend it

Let's get the mechanics straight, because "secondaries fund" gets thrown around loosely and it matters exactly what kind of buyer Adams Street is being here.

A private equity secondary is simply the resale of an existing stake in a private fund or a private company, rather than a brand-new investment. There are two flavors, and Adams Street plays in both:

• LP-led deals: A limited partner (a pension fund, an endowment, a family office) wants out of its position in a buyout fund before the fund's natural 10-to-12-year life is up. It sells its stake, usually at a discount to net asset value (NAV, the fund's own reported value of its holdings), to a secondaries buyer like Adams Street.
• GP-led deals: The general partner running the fund, not the limited partner, initiates the transaction. The most common structure is a continuation fund: the GP rolls one or several of its best remaining portfolio companies into a new vehicle, existing LPs get the choice to cash out or roll forward, and a secondaries buyer comes in to price the deal and provide the exit liquidity for those who want out.

Adams Street has told the market it wants Fund 8's capital split roughly 50/50 between those two paths, per Private Equity Wire's coverage of the close, a figure also confirmed in Alternatives Watch's reporting on the fund close. That 50/50 target is itself a signal. Five years ago, most secondaries shops were overwhelmingly LP-led buyers, picking up stakes that pensions needed to offload for portfolio rebalancing. GP-led deals were treated as a specialty sleeve, something you dabbled in opportunistically. Adams Street is now running it as a coequal strategy. Secondaries Investor reports that roughly half of Adams Street's actual deployment has been going into single-asset and multi-asset continuation funds, which confirms the GP-led allocation isn't just a marketing slide. The fund's stated focus is North America and Europe, with an emphasis on the lower middle market, meaning smaller buyout-backed companies where fewer large secondaries funds compete for deal flow and pricing tends to be less picked-over than in the mega-cap continuation fund deals that dominate headlines (think Clayton, Dubilier & Rice or Blackstone-sized names).

For context on scale, Adams Street manages more than $73 billion in total assets under management, is 100% employee-owned, and has been running secondaries strategies for over two decades. This isn't a first-time manager chasing a hot trend. It's an established shop scaling up an existing playbook because demand from limited partners outstripped what it planned to raise.

Table: Adams Street's secondaries program, then versus now

Metric	2023 Program	2026 Program (Fund 8 + SMAs)
Total capital raised	$3.2 billion	$5.0+ billion
Flagship fund size	Undisclosed target, smaller vintage	$2.7 billion (vs. $2 billion target)
Related SMA capital	Included in $3.2B total	$2.3 billion
Strategy split	LP-led weighted	Target 50/50 LP-led / GP-led
Geographic focus	North America / Europe	North America / Europe, lower mid-market emphasis

Why this matters beyond one firm's fundraising win

Here's my read as someone who has spent two decades around institutional allocators: this raise is a symptom, not a cause. The underlying disease, if you want to call it that, is exit constipation across the buyout industry. Private equity firms raised enormous sums in 2020 and 2021 at high valuations. Interest rates then rose, IPO windows shut for long stretches, and strategic acquirers got choosier. The result is a pile of portfolio companies that GPs have held for six, seven, eight years, well past the typical four-to-six-year hold period, with no easy exit in sight. That pile of aging, illiquid holdings is exactly what secondaries buyers exist to solve. When a GP can't sell a good company to a strategic buyer or take it public, but LPs in the fund want their money back, a continuation fund lets everyone get what they need: the GP keeps managing an asset it knows well and believes still has upside, departing LPs get cash, and new secondaries investors like Adams Street get to buy into a proven, de-risked company at a negotiated price, typically at some discount to the GP's own marked NAV.

The Evercore data backs up the scale of this shift. Per AI-CIO's coverage of Evercore's 2025 secondary market report, LP-led volume rose 34% to 35% year over year to roughly $120 billion, while GP-led volume rose about 50% to 51% to roughly $106 billion. Both sides of the market grew at a rate that dwarfs overall private equity fundraising growth. LPs are selling more because they need liquidity and because more of them now view active portfolio management, meaning periodically trimming and rebalancing private holdings the way you'd rebalance a public stock portfolio, as standard practice rather than a sign of distress. GPs are running more continuation vehicles because it's become a normalized way to return capital without a full exit. If you're an accredited investor with private equity or private credit exposure through a feeder fund, a fund-of-funds, or a direct LP commitment, this is the market context you're operating in. Secondaries funds are no longer a niche corner of alternatives. They're becoming a structural piece of how institutional capital gets recycled through the private markets, and Adams Street doubling its fund size is one data point among several telling you allocators believe that trend has years left to run.

What the press release doesn't say

Now for the part Adams Street's PR team is not going to volunteer. First, a 50% jump in fund size over three years is not automatically a sign of skill. It's partly a sign of category momentum. When an asset class goes from a niche allocation to a must-have line item in institutional portfolios, established managers with a two-decade track record collect disproportionate inflows almost regardless of whether their next fund will outperform their last one. Fund size and manager skill are not the same thing, and bigger funds bring their own drag: more capital to deploy in a fixed window means either accepting more deals at thinner discounts or reaching into deal sizes and geographies the strategy wasn't originally built for. Ask any LP who lived through the 2007 buyout mega-fund vintage what happens when strong fundraising outpaces strong deal discipline. Second, "discount to NAV" is doing a lot of quiet work in every secondaries pitch, including Adams Street's, and NAV is an estimate, not a market price. GPs mark their own portfolio companies, typically once a quarter, using models and comparable-company multiples that can lag real market conditions by two quarters or more. A secondaries buyer who pays "85 cents on the dollar" relative to NAV isn't necessarily getting a bargain if the underlying NAV itself is stale or optimistic. The 2022 to 2023 stretch, when public market multiples fell sharply but private marks moved down much more slowly, is the textbook case. Anyone buying secondaries in that window at a discount to NAV was still buying into marks that hadn't fully caught down yet. I'm not saying that's happening again right now, but I am saying the discount number in a secondaries pitch deck tells you less than it sounds like it tells you. Third, GP-led continuation funds carry a conflict of interest that doesn't disappear just because it's disclosed. The GP running the continuation fund is the same GP who managed the original fund, set the exit price, and often keeps an economic stake and control over the asset after the new deal closes. They are, in effect, selling to themselves, using a third party like Adams Street to set an "arm's length" price. Guidance from the Institutional Limited Partners Association (ILPA) and increased SEC scrutiny under the Private Fund Adviser rules (portions of which were vacated by the Fifth Circuit in 2024, but which pushed the industry toward more voluntary disclosure regardless, as covered by the SEC's own release on the adopted rules) have pushed managers toward independent fairness opinions and LP advisory committee sign-off on these deals. That's real progress. But it doesn't eliminate the structural tension of a GP deciding which of its own portfolio companies to keep and which to let its outside LPs exit from at a price the GP has real influence over. Fourth, "lower mid-market" is where Adams Street says less competition exists, and that's plausible, but it's also the segment where deal information is thinnest, where portfolio company financials are least standardized, and where a secondaries buyer's underwriting depends more heavily on trusting the selling GP's numbers. Less competition can mean better pricing. It can also mean the deal is harder to price correctly for good reason.

What accredited investors should actually watch for

If you have exposure to secondaries, whether through a fund-of-funds allocation, a direct commitment, or a semi-liquid interval fund that touches this space, here's what I'd track over the next 12 to 18 months:

• Deployment pace versus fund life. A $5 billion program raised faster than its predecessor needs a deal pipeline to match. Watch whether Adams Street (or any secondaries manager you're invested with) is deploying on schedule or sitting on dry powder because pricing hasn't come down enough to hit return targets.
• Discount-to-NAV trends across the market, not just one deal. Evercore, Jefferies, and Lazard all publish periodic secondary market pricing surveys. If average discounts to NAV are compressing sharply as more capital chases fewer deals, that's a sign the easy money in secondaries has already been made.
• Continuation fund fairness opinion practices. If you're evaluating a GP-led deal or a fund that participates heavily in them, ask whether an independent third party priced the transaction and whether the LP advisory committee actually had the leverage to push back, not just the right to be consulted.
• Concentration risk in single-asset continuation funds. A multi-asset continuation fund spreads risk across several companies. A single-asset continuation fund is a bet on one company's next three to five years, dressed up in fund structure. Know which one you're in.
• Your own liquidity assumptions. Secondaries funds are often pitched as a way to get J-curve mitigation (faster, earlier returns than a traditional blind-pool fund because you're buying already-seasoned assets). That's often true. It does not make these funds liquid. Capital is still typically locked up for years.

Adams Street's $5 billion-plus raise is a real, well-earned validation of a two-decade-old strategy meeting a moment when the broader private equity industry needs exactly what secondaries buyers provide: liquidity for sellers, discounted access for buyers, and a release valve for a system full of aging, unexited holdings. I think that's a legitimately good setup for disciplined secondaries managers over the next few years. I also think the size of this raise, and the broader $226 billion market Evercore is tracking, means you should expect more capital chasing the same deals, thinner discounts than early movers got, and more scrutiny on exactly how "independent" a GP-led continuation fund pricing process really is. Read the fund documents. Ask who priced the deal. And don't confuse a bigger fund with a better one.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.